Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis

Journal of Bacteriology

Volumn 193, Issue 19, 2011, Pages 5600-5601

  Gomes, Leonardo H F ^a   Otto, Thomas D ^a,b,c   Vasconcellos, Érico A ^a,b   Ferrão, Patrícia M ^a   Maia, Renata M ^b   Moreira, Aline S ^a   Ferreira, Marcelo A ^a   Castello Branco, Luiz R R ^b   Degrave, Wim M ^a   Mendonça Lima, Leila ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro de Pesquisas Arlindo de Assis   (Brazil)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; RIBOSOME RNA; TRANSFER RNA;

BACTERIAL GENOME; BRAZIL; DNA SEQUENCE; MYCOBACTERIUM BOVIS; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN IDENTIFICATION; TUBERCULOSIS; VACCINATION; VACCINE PRODUCTION;

BCG VACCINE; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 80053595738     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.05827-11     Document Type: Note

References (19)

1. Behr, M., et al. 1999. Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284:1520-1523.
2. Benévolo-de-Andrade, T. C., R. Monteiro-Maia, C. Cosgrove, and L. R. Castello-Branco. 2005. BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis. Review. Mem. Inst. Oswaldo Cruz 100:459-465.
3. Berrêdo-Pinho, M., et al. 2011. Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur. BMC Microbiol. 11:80.
4. Brosch, R., et al. 2007. Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci. U. S. A. 104:5596-5601.
5. Calmette, A. 1928. La vaccination preventive de la tuberculose par le BCG (bacille Calmette-Guérin). Rapport présenté à la Conférence Internationale du BCG réunie à Paris du 15 au 18 octobre 1928 et organisépar la Section d'Hygiène de la Sociétédes Nations. Ann. Inst. Pasteur 42(Suppl.):1-60.
6. Cole, S. T., et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
7. Garnier, T., et al. 2003. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U. S. A. 100:7877-7882.
8. Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:195-202.
9. Hayashi, D., et al. 2009. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains. FEMS Immunol. Med. Microbiol. 56:116-128.
10. Kozak, R., and M. A. Behr. 2011. Divergence of immunologic and protective responses of different BCG strains in a murine model. Vaccine 29:1519-1526.
11. Leung, A. S., et al. 2008. Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC Genomics 9:413.
12. Mostowy, S., A. G. Tsolaki, P. M. Small, and M. A. Behr. 2003. The in vitro evolution of BCG vaccines. Vaccine 21:4270-4274.
13. Oettinger, T., M. Jørgensen, A. Ladefoged, K. Hasløv, and P. Andersen. 1999. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber. Lung Dis. 79:243-250.
14. Otto, T. D., et al. 2008. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet. Mol. Res. 7:861- 871.
15. Otto, T. D., G. P. Dillon, W. S. Degrave, and M. Berriman. 2011. RATT: rapid annotation transfer tool. Nucleic Acids Res. 39:e57.
16. Pan, Y., et al. 2011. Whole-genome sequences of four Mycobacterium bovis BCG vaccine strains. J. Bacteriol. 193:3152-3153.
17. Rutherford, K., et al. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.
18. Seki, M., et al. 2009. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains. Vaccine 27:1710-1716.
19. World Health Organization. 2010. WHO vaccine-preventable disease monitoring system, 2010 global summary, section 2: reference country immunization profiles. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2010/WHO_IVB_2010_eng_p32-R242.pdf.